Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children’s Oncology Group study

医学 微小残留病 内科学 免疫分型 胃肠病学 淋巴细胞白血病 白血病 免疫学 流式细胞术
作者
Brent L. Wood,Meenakshi Devidas,Ryan J. Summers,Zhiguo Chen,Barbara L. Asselin,Karen R. Rabin,Patrick A. Zweidler‐McKay,Naomi J. Winick,Michael J. Borowitz,William L. Carroll,Elizabeth A. Raetz,Mignon L. Loh,Stephen P. Hunger,Kimberly P. Dunsmore,David T. Teachey,Stuart S. Winter
出处
期刊:Blood [Elsevier BV]
卷期号:142 (24): 2069-2078 被引量:21
标识
DOI:10.1182/blood.2023020678
摘要

Abstract The early thymic precursor (ETP) immunophenotype was previously reported to confer poor outcome in T-cell acute lymphoblastic leukemia (T-ALL). Between 2009 and 2014, 1256 newly diagnosed children and young adults enrolled in Children’s Oncology Group (COG) AALL0434 were assessed for ETP status and minimal residual disease (MRD) using flow cytometry at a central reference laboratory. The subject phenotypes were categorized as ETP (n = 145; 11.5%), near-ETP (n = 209; 16.7%), or non-ETP (n = 902; 71.8%). Despite higher rates of induction failure for ETP (6.2%) and near-ETP (6.2%) than non-ETP (1.2%; P < .0001), all 3 groups showed excellent 5-year event-free survival (EFS) and overall survival (OS): ETP (80.4% ± 3.9% and 86.8 ± 3.4%, respectively), near-ETP (81.1% ± 3.3% and 89.6% ± 2.6%, respectively), and non-ETP (85.3% ± 1.4% and 90.0% ± 1.2%, respectively; P = .1679 and P = .3297, respectively). There was no difference in EFS or OS for subjects with a day-29 MRD <0.01% vs 0.01% to 0.1%. However, day-29 MRD ≥0.1% was associated with inferior EFS and OS for patients with near-ETP and non-ETP, but not for those with ETP. For subjects with day-29 MRD ≥1%, end-consolidation MRD ≥0.01% was a striking predictor of inferior EFS (80.9% ± 4.1% vs 52.4% ± 8.1%, respectively; P = .0001). When considered as a single variable, subjects with all 3 T-ALL phenotypes had similar outcomes and subjects with persistent postinduction disease had inferior outcomes, regardless of their ETP phenotype. This clinical trial was registered at AALL0434 as #NCT00408005.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sqw发布了新的文献求助10
2秒前
douzi完成签到,获得积分10
2秒前
猴子好坏完成签到,获得积分10
3秒前
小马不爱学习完成签到,获得积分10
3秒前
4秒前
mukji发布了新的文献求助10
5秒前
山外山完成签到,获得积分10
6秒前
logan完成签到,获得积分10
7秒前
顾欢欢完成签到 ,获得积分10
8秒前
苦瓜女生发布了新的文献求助10
10秒前
11秒前
清脆香露完成签到,获得积分10
11秒前
赘婿应助小远远采纳,获得10
11秒前
领导范儿应助软土豆丝采纳,获得10
12秒前
Skyrin完成签到,获得积分0
12秒前
Orange应助无限毛豆采纳,获得10
13秒前
biyeshunli完成签到,获得积分20
14秒前
15秒前
芳芳子呀完成签到,获得积分10
15秒前
Akim应助子云采纳,获得10
17秒前
paul完成签到,获得积分10
17秒前
123lx完成签到,获得积分10
17秒前
20秒前
77发布了新的文献求助10
20秒前
21秒前
star完成签到 ,获得积分10
21秒前
22秒前
sjw525完成签到,获得积分10
23秒前
威武白桃完成签到,获得积分10
24秒前
24秒前
科研小白完成签到,获得积分10
24秒前
gqp完成签到,获得积分10
25秒前
无限毛豆发布了新的文献求助10
26秒前
眼睛大的傲菡完成签到,获得积分10
26秒前
科研豪97发布了新的文献求助10
26秒前
软土豆丝发布了新的文献求助10
29秒前
Lucas应助YULIA采纳,获得30
37秒前
4444小熊完成签到 ,获得积分10
39秒前
我要查文献完成签到 ,获得积分10
42秒前
懦弱的叫兽完成签到 ,获得积分10
44秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3671625
求助须知:如何正确求助?哪些是违规求助? 3228325
关于积分的说明 9779625
捐赠科研通 2938636
什么是DOI,文献DOI怎么找? 1610180
邀请新用户注册赠送积分活动 760547
科研通“疑难数据库(出版商)”最低求助积分说明 736093